Brainlab Elements Image Fusion, Contouring (4.5);Image Fusion  (4.5);Fibertracking (2.0);BOLD MRI Mapping  (1.0);Image Fusion Angio  (1.0)

Brainlab Elements 6.0 is a comprehensive medical image processing software suite designed to enhance image-guided surgery and radiation treatment planning by providing tools for advanced image co-registration, segmentation, DTI fibertracking, BOLD MRI mapping, and cerebrovascular image analysis. The system employs sophisticated algorithms, including a new AI-driven Convolutional Neural Network for tumor identification, and has undergone verification and pre-clinical validation to ensure its performance, safety, and usability in clinical settings.

Brainlab Elements 6.0 is a suite of software applications designed for processing medical image data to support image-guided surgery and radiation treatment planning. It facilitates the transfer of DICOM data and includes modules for 2D/3D image viewing, processing, co-registration, segmentation, and 3D visualization. Key components include: Elements Contouring for outlining and manipulating anatomical structures from image data (outputting 3D DICOM segmentation objects); Elements Image Fusion for aligning anatomical structures through co-registration of various imaging modalities (CT, MRI, PET, SPECT, US) using rigid and deformable methods; Elements Fibertracking for processing and visualizing cranial white matter tracts from DTI data; Elements BOLD MRI Mapping for analyzing task-based BOLD MRI data to visualize neural activation signals; and Elements Image Fusion Angio for co-registering cerebrovascular image data, such as fusing 2D DSA with MRA/CTA/3D DSA to combine flow and location information. The system incorporates advanced image processing algorithms, including a significant update with an AI/ML-based feature for identifying previously diagnosed lesions or tumors in T1-weighted contrast-enhanced MR images. This Convolutional Neural Network (CNN), developed via supervised learning, complements a pre-existing non-ML tumor segmentation algorithm and is preferred when suitable MR volumes are available. New functionalities, such as automatic fusion of US to MR images in Image Fusion and optional distortion correction in BOLD MRI Mapping, have been introduced. The system's performance and safety were established through comprehensive software verification (integration tests, unit tests, cybersecurity checks) and pre-clinical validation activities. These validations confirmed that the device provides state-of-the-art features for pre-surgical and radiotherapy planning, meets safety and performance requirements with adequate risk mitigation, and offers clinical benefits that outweigh potential risks, with usability affirmed for the intended user group.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the performance of the new AI/ML-based tumor segmentation algorithm (CNN) compare quantitatively to the previous non-ML algorithm and to other state-of-the-art segmentation methods in terms of accuracy, sensitivity, and specificity on diverse datasets?; What specific image characteristics or data quality thresholds determine when the AI/ML algorithm is "preferred" over the non-ML tumor segmentation algorithm for T1+C MR volumes?; Can the Brainlab Elements Fibertracking module integrate with functional data (e.g., from BOLD MRI Mapping) to provide a more comprehensive map of eloquent brain areas and their connectivity for surgical planning?; What are the computational performance metrics (e.g., processing time, memory usage) for the deformable registration methods in Image Fusion, particularly when handling large or multiple volumetric datasets?; How does the system ensure the accuracy and reliability of co-registering 2D DSA sequences with 3D volumetric data (MRA, CTA, 3D DSA) in Image Fusion Angio, given the inherent dimensional differences and potential for projection errors?